Psomagen Statistics

Total Valuation

Psomagen has a market cap or net worth of KRW 67.04 billion. The enterprise value is 66.11 billion.

Market Cap	67.04B
Enterprise Value	66.11B

Important Dates

The last earnings date was Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Psomagen has 19.24 million shares outstanding. The number of shares has decreased by -8.46% in one year.

Current Share Class	n/a
Shares Outstanding	19.24M
Shares Change (YoY)	-8.46%
Shares Change (QoQ)	-21.15%
Owned by Insiders (%)	20.31%
Owned by Institutions (%)	n/a
Float	8.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.57
PB Ratio	2.78
P/TBV Ratio	2.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-11.77
EV / Sales	1.51
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-66.02

Financial Position

The company has a current ratio of 1.62, with a Debt / Equity ratio of 0.37.

Current Ratio	1.62
Quick Ratio	1.19
Debt / Equity	0.37
Debt / EBITDA	n/a
Debt / FCF	-11.30
Interest Coverage	-10.38

Financial Efficiency

Return on equity (ROE) is -19.93% and return on invested capital (ROIC) is -8.29%.

Return on Equity (ROE)	-19.93%
Return on Assets (ROA)	-6.54%
Return on Invested Capital (ROIC)	-8.29%
Return on Capital Employed (ROCE)	-13.48%
Revenue Per Employee	474.61M
Profits Per Employee	-61.06M
Employee Count	89
Asset Turnover	0.87
Inventory Turnover	6.58

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.77% in the last 52 weeks. The beta is 0.10, so Psomagen's price volatility has been lower than the market average.

Beta (5Y)	0.10
52-Week Price Change	-31.77%
50-Day Moving Average	3,918.20
200-Day Moving Average	4,258.50
Relative Strength Index (RSI)	20.45
Average Volume (20 Days)	16,800

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Psomagen had revenue of KRW 43.66 billion and -5.62 billion in losses. Loss per share was -286.00.

Revenue	43.66B
Gross Profit	9.57B
Operating Income	-5.23B
Pretax Income	-6.22B
Net Income	-5.62B
EBITDA	-96.26M
EBIT	-5.23B
Loss Per Share	-286.00

Full Income Statement

Balance Sheet

The company has 11.76 billion in cash and 11.31 billion in debt, giving a net cash position of 446.45 million or 23.21 per share.

Cash & Cash Equivalents	11.76B
Total Debt	11.31B
Net Cash	446.45M
Net Cash Per Share	23.21
Equity (Book Value)	30.29B
Book Value Per Share	1,255.37
Working Capital	10.26B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.30 billion and capital expenditures -4.30 billion, giving a free cash flow of -1.00 billion.

Operating Cash Flow	3.30B
Capital Expenditures	-4.30B
Free Cash Flow	-1.00B
FCF Per Share	-52.06

Full Cash Flow Statement

Margins

Gross margin is 21.92%, with operating and profit margins of -11.98% and -12.87%.

Gross Margin	21.92%
Operating Margin	-11.98%
Pretax Margin	-14.25%
Profit Margin	-12.87%
EBITDA Margin	-0.22%
EBIT Margin	-11.98%
FCF Margin	n/a

Dividends & Yields

Psomagen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	8.46%
Shareholder Yield	8.46%
Earnings Yield	-8.38%
FCF Yield	-1.49%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Psomagen has an Altman Z-Score of 0.6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.6
Piotroski F-Score	n/a